These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15790915

  • 1. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation.
    Varano M, Parisi V, Tedeschi M, Sciamanna M, Gallinaro G, Capaldo N, Catalano S, Pascarella A.
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1453-62. PubMed ID: 15790915
    [Abstract] [Full Text] [Related]

  • 2. Photodynamic therapy in subfoveal and juxtafoveal myopic choroidal neovascularization: a 10-year retrospective analysis.
    Varano M, Iacono P, Giorno P, Chiaravalloti A, Parravano M.
    Ophthalmologica; 2014 Apr; 231(4):204-10. PubMed ID: 24481122
    [Abstract] [Full Text] [Related]

  • 3. Comparison of foveal-sparing with foveal-involving photodynamic therapy for myopic choroidal neovascularization.
    Tan CS, Chew MC, Lim TH.
    Eye (Lond); 2014 Jan; 28(1):17-22. PubMed ID: 24051405
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Progression of myopic maculopathy after treatment of choroidal neovascularization.
    Farinha CL, Baltar AS, Nunes SG, Figueira JP, Pires IA, Cachulo ML, Silva RM.
    Ophthalmologica; 2014 Jan; 231(4):211-20. PubMed ID: 24662778
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
    Pece A, Vadalà M, Isola V, Matranga D.
    Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
    [Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM, Lai S, Markey CM.
    Clin Exp Ophthalmol; 2007 Mar; 35(1):24-31. PubMed ID: 17300567
    [Abstract] [Full Text] [Related]

  • 8. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K, Ohno-Matsui K, Teramukai S, Shimada N, Moriyama M, Hayashi W, Yoshida T, Tokoro T, Mochizuki M.
    Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
    [Abstract] [Full Text] [Related]

  • 9. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R, Gabric N.
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [Abstract] [Full Text] [Related]

  • 10. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A, Isola V, Vadalà M, Matranga D.
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [Abstract] [Full Text] [Related]

  • 11. Choroidal thickness after treatment for myopic 
choroidal neovascularization.
    Farinha CL, Baltar AS, Nunes SG, Franqueira NF, Figueira JP, Pires IA, Cachulo ML, Silva RM.
    Eur J Ophthalmol; 2013 Sep; 23(6):887-98. PubMed ID: 23787449
    [Abstract] [Full Text] [Related]

  • 12. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results.
    Scupola A, Tiberti AC, Sasso P, Savastano MC, Mastrocola A, Marangoni D, Minnella AM, Falsini B, Balestrazzi E.
    Retina; 2010 May; 30(5):739-47. PubMed ID: 20038860
    [Abstract] [Full Text] [Related]

  • 13. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.
    Axer-Siegel R, Ehrlich R, Weinberger D, Rosenblatt I, Shani L, Yassur Y, Priel E, Kramer M.
    Am J Ophthalmol; 2004 Oct; 138(4):602-7. PubMed ID: 15488787
    [Abstract] [Full Text] [Related]

  • 14. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [Abstract] [Full Text] [Related]

  • 15. Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: a two-year study.
    Glacet-Bernard A, Benyelles N, Dumas S, Haddad WM, Voigt M, Razavi S, Roquet W, Coscas G, Soubrane G.
    Am J Ophthalmol; 2007 Jan; 143(1):68-76. PubMed ID: 17188042
    [Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy for nonsubfoveal choroidal neovascularization in 100 eyes with pathologic myopia.
    Virgili G, Varano M, Giacomelli G, Arena MC, Tedeschi M, Pascarella A, Catalano S, Menchini U.
    Am J Ophthalmol; 2007 Jan; 143(1):77-82. PubMed ID: 17188043
    [Abstract] [Full Text] [Related]

  • 17. Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes.
    Hussain N, Khanna R, Das T, Narayanan R, Sunday OT, Bansal AG, Reddy R.
    Indian J Ophthalmol; 2008 Jan; 56(6):465-8. PubMed ID: 18974516
    [Abstract] [Full Text] [Related]

  • 18. A preliminary assessment of macular function by MF-ERG in myopic eyes with CNV with complete response to photodynamic therapy.
    Moschos MN, Panayotidis D, Moschos MM, Bouros C, Theodossiadis PG, Theodossiadis GP.
    Eur J Ophthalmol; 2003 Jun; 13(5):461-7. PubMed ID: 12841569
    [Abstract] [Full Text] [Related]

  • 19. The changes of pattern electroretinography at the early stage of photodynamic therapy.
    Oner A, Karakucuk S, Mirza E, Erkilic K.
    Doc Ophthalmol; 2005 Sep; 111(2):107-12. PubMed ID: 16514492
    [Abstract] [Full Text] [Related]

  • 20. Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.
    Costagliola C, Campa C, Incorvaia C, Parmeggiani F, Menzione M, Della Corte M, Rinaldi M, Romano M, Semeraro F.
    Eur J Ophthalmol; 2008 Sep; 18(6):955-9. PubMed ID: 18988168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.